Evidence map›Paper›PMID 18353631›Full record

Trial reportEuropean journal of cancer (Oxford, England : 1990)2008

Morphological features and molecular markers in rectal cancer from 95 patients included in the European Organisation for Research and Treatment of Cancer 22921 trial: prognostic value and effects of preoperative radio (chemo) therapy.

Annelies Debucquoy, Louis Libbrecht, Valerie Roobrouck, Laurence Goethals, William McBride, Karin Haustermans

Open access · greenAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in European journal of cancer (Oxford, England : 1990), 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 27 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Gene expression analysis in chronic postradiation proctopathy.International journal of colorectal disease · 2012
    Article
  7. Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Annelies DebucquoyDepartment of Radiation Oncology, Leuven Cancer Institute, University Hospital Leuven, Belgium. annelies.debucquoy@med.kuleuven.be
Louis Libbrecht
Valerie Roobrouck
Laurence Goethals
William McBride
Karin Haustermans
KU Leuven · BEAZ Groeninge · BEUniversity of California, Los Angeles · US

Funding

Radiation Affects Tumor Antigen PresentationR01CA101752 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI MCBRIDE, WILLIAM H. · 2003 to 2007
$1.7M
NCI NIH HHS R01 CA101752
6 · The paper itself

Abstract

In this study, the prognostic and/or predictive value of different proteins (cyclo-oxygenase 2 (COX-2), Ki67 and cleaved cytokeratin (CK) 18) and fibro-inflammatory changes which might be of importance for the response to treatment were evaluated using tissue micro arrays. Samples were obtained from a subset of 95 patients included in the European Organisation for Research and Treatment of Cancer 22921 clinical trial, which randomised patients with rectal cancer to one of four arms treated with preoperative radiotherapy with or without pre- and/or postoperative chemotherapy. From our results, we can conclude that the addition of preoperative chemotherapy to radiotherapy led to significantly less COX-2 upregulation, less proliferation and more inflammation, as was seen in the resection specimen as well as less invasion and metastasis. For COX-2, Ki67 or cleaved CK18, no predictive or prognostic value could be identified. However, the fibro-inflammatory reaction after preoperative radiochemotherapy correlated with T-downstaging and seems to be an important factor for response.

Indexed as

AgedAntineoplastic Combined Chemotherapy ProtocolsCyclooxygenase 2Disease-Free SurvivalFibrosisHumansImmunohistochemistryKeratin-18Ki-67 AntigenMiddle AgedPreoperative CareProctitisPrognosisProtein Array AnalysisRectal NeoplasmsRectumCyclooxygenase 2Keratin-18Ki-67 Antigen

Identifiers

PMID18353631
PMCPMC2673997
OpenAlexW2126069428

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.